Itracoe 200 Capsule contains Itraconazole 200 mg, a broad-spectrum triazole antifungal agent effective against a wide range of fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting cell membrane integrity and leading to fungal cell death. This medication is indicated for the treatment of various systemic and superficial mycoses, including aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and candidiasis. Itracoe 200 is particularly useful in patients who require oral antifungal therapy with good bioavailability and tissue penetration. The capsule formulation should be taken with food to enhance absorption. Dosage and duration of therapy depend on the type and severity of infection and should be determined by a healthcare professional. Common adverse effects may include gastrointestinal disturbances, headache, dizziness, and elevated liver enzymes; therefore, liver function tests should be monitored during prolonged therapy. Itracoe 200 should be used cautiously in patients with hepatic impairment and those taking medications metabolized by the cytochrome P450 system due to potential drug interactions. It is contraindicated in patients with known hypersensitivity to itraconazole or other azole antifungals. Proper medical supervision is essential to ensure safe and effective use of this antifungal agent.